切换至 "中华医学电子期刊资源库"

中华结直肠疾病电子杂志 ›› 2024, Vol. 13 ›› Issue (01) : 78 -82. doi: 10.3877/cma.j.issn.2095-3224.2024.01.013

病例报道

肛管直肠黑色素瘤10例临床分析并文献复习
施波1, 邰清亮1, 陈国梁1, 侍新宇1, 姚慧慧1, 陈俊杰1, 沈成龙2, 周国强2, 顾闻1, 刘峰3,(), 何宋兵1,()   
  1. 1. 215000 苏州大学附属第一医院普外科
    2. 215000 常熟市第二人民医院胃肠外科
    3. 215028 苏州永鼎医院普外科
  • 收稿日期:2023-06-16 出版日期:2024-02-25
  • 通信作者: 刘峰, 何宋兵
  • 基金资助:
    江苏省自然科学基金(No. BK20191172); 苏州市医工结合协同创新研究项目(No. SLJ2021007); 苏州市姑苏卫生重点人才项目(No. GSWS2020005)

Clinical analysis and review of 10 cases of anorectal malignant melanoma

Bo Shi1, Qingliang Tai1, Guoliang Chen1, Xinyu Shi1, Huihui Yao1, Junjie Chen1, Chenglong Shen2, Guoqiang Zhou2, Wen Gu1, Feng Liu3,(), Songbing He1,()   

  1. 1. Department of General Surgery, First Affiliated Hospital of Soochow University, Suzhou 215000, China
    2. Department of Gastrointestinal Surgery, Changshu No. 2 Hospital, Suzhou 215000, China
    3. Department of General Surgery, Suzhou Yongding Hospital, Suzhou 215028, China
  • Received:2023-06-16 Published:2024-02-25
  • Corresponding author: Feng Liu, Songbing He
引用本文:

施波, 邰清亮, 陈国梁, 侍新宇, 姚慧慧, 陈俊杰, 沈成龙, 周国强, 顾闻, 刘峰, 何宋兵. 肛管直肠黑色素瘤10例临床分析并文献复习[J]. 中华结直肠疾病电子杂志, 2024, 13(01): 78-82.

Bo Shi, Qingliang Tai, Guoliang Chen, Xinyu Shi, Huihui Yao, Junjie Chen, Chenglong Shen, Guoqiang Zhou, Wen Gu, Feng Liu, Songbing He. Clinical analysis and review of 10 cases of anorectal malignant melanoma[J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2024, 13(01): 78-82.

目的

探讨肛管直肠恶性黑色素瘤(ARMM)的临床病理特征及诊治方法。

方法

回顾性分析苏州大学附属第一医院2011~2021年间收治的ARMM10例并结合文献复习,对其临床资料、病理特点、治疗结果和预后情况进行探讨并总结诊治经验。

结果

10例ARMM患者中,男性4例,女性6例;年龄50~79岁,平均发病年龄(61.4±7.6)岁。患者临床表现多样,但以便血为主,缺乏特异性,所有患者术前行CEA,CA19-9定量检测结果均正常;10例患者中,9例行免疫组化染色,其中主要指标有S-100、HBM、MelanA、Ki-67,9例患者S-100均为阳性;HBM8例阳性;MelanA除4例未查外,4例阳性,1例阴性。9例患者Ki-67均为阳性,其中5例阳性区>50%。6例接受腹会阴联合肿瘤切除术(Miles术),4例接受经肛门直肠肿物切除术;5例术后接受综合治疗,1例术后因泌尿系转移行尿道切除术,4例术后未行辅助治疗。患者总体生存期5.5个月~108个月,平均生存(30.6±29.5)个月,中位生存期28.0个月。

结论

ARMM是一种临床上罕见且恶性程度极高的恶性肿瘤,临床表现不典型,主要通过病理活检来确诊,对于确诊患者行腹会阴联合切除是主要的手术方式,术后可以辅助放化疗和免疫治疗。

Objective

To investigate the clinicopathological features, diagnosis and treatment of anorectal malignant melanoma(ARMM).

Methods

From 2011 to 2021, ten cases of ARMM confirmed by pathological examination were analyzed retrospectively. Combined with relevant literature, we discussed the clinical data, pathological features, treatment results, prognosis and summarized the experience of diagnosis and treatment.

Results

Among the 10 patients with ARMM,four were males and 6 were females, with the age ranged from 50 to 79 years old, and the average age of (61.4±7.6) years. The clinical manifestations are diverse and non-specific, but mainly bloody stools. The results of CEA, CA19-9 quantitative detection were normal in all patients before operation. Immunohistochemistry was performed in 9 cases, we mainly tested S-100, HBM, MelanA, Ki-67. S-100 was positive in 9 cases, HBM was positive in 8 cases, MelanA was positive in 4 cases and negative in one case except 4 cases. Ki-67 was positive in 9 cases, of which 5 cases had a positive area > 50%. The 6 cases were submitted to abdominoperineal resection, and 4 cases were submitted to local resection of anorectal tumor. The 5 cases received multimodality therapy after operation, one case was submitted to urethrotomy because of urinary metastasis after operation, and 4 cases did not receive any therapy.The overall survival time of patients in this group was 5.5~108 months, the average time was (30.6±29.5) months, the median survival time was 28 months.

Conclusion

ARMM is a rare and highly malignant tumor with atypical clinical manifestations, which is mainly diagnosed by pathological biopsy,but digital anorectal examination plays an important role in the early detection of ARMM. Abdominoperineal resection is the main surgical method for confirmed patients. Radiotherapy, chemotherapy and immunotherapy can be supplemented.

表1 9例患者免疫组化主要指标染色结果
表2 10例ARMM患者的临床症状及预后分析
[1]
Nigam JS, Nishit, Kumar T, et al. Anorectal melanoma-brownish black mass not always a hemorrhoid [J]. J Gastrointest Cancer, 2022, 53(3): 825-829.
[2]
中国抗癌协会,中国抗癌协会大肠癌专业委员会.中国恶性肿瘤整合诊治指南-肛管癌部分[J/OL].中华结直肠疾病电子杂志, 2022, 11(1): 13-17.
[3]
王锡山.肛管直肠恶性黑色素瘤诊治指南解读[J/CD].中华结直肠疾病电子杂志, 2015, 4(2): 15-17.
[4]
中国临床肿瘤学会指南工作委员会.黑色素瘤诊疗指南2022[M].北京:人民卫生出版社, 2022.
[5]
曹龙磊,周启昌,于杰,等.老年肛管直肠恶性黑色素瘤、腺癌伴Paget病与鳞癌的复合癌一例[J].中华胃肠外科杂志, 2016, 19(12): 1434-1435.
[6]
Slingluff CLJr, Vollmer RT, Seigler HF. Anorectal melanoma: clinical characteristics and results of surgical management in twenty-four patients [J]. Surgery, 1990, 107(1): 1-9.
[7]
Pessaux P, Pocard M, Elias D, et al. Surgical management of primary anorectal melanoma [J]. Br J Surg, 2004, 91(9): 1183-1187.
[8]
陈勇,叶红.肛管直肠恶性黑色素瘤6例临床病理学分析[J].肿瘤学杂志, 2017, 23(10): 928-930.
[9]
魏雪静,张彦宁,徐瑞,等.原发性消化道黑色素瘤14例临床病理分析[J].临床与实验病理学杂志, 2021, 37(6): 655-659.
[10]
邹振玉,刘海亮,孙培鸣,等.肛管直肠恶性黑色素瘤34例治疗与预后分析[J].中华胃肠外科杂志, 2013, 16(5): 459-462.
[11]
Tracey EH, Vij A. Updates in melanoma [J]. Dermatol Clin, 2019, 37(1): 73-82.
[12]
李燕,徐青,余静,等.肛管直肠原发性恶性黑色素瘤的CT和MRI诊断:2例报告并文献复习[J].医学影像学杂志, 2016, 26(1): 153-156.
[13]
Puglisi R, Bellenghi M, Pontecorvi G, et al. Biomarkers for diagnosis, prognosis and response to immunotherapy in melanoma[J]. Cancers (Basel), 2021, 13(12): 2875.
[14]
Eisenstein A, Gonzalez EC, Raghunathan R, et al. Emerging biomarkers in cutaneous melanoma[J]. Mol Diagn Ther, 2018, 22(2): 203-218.
[15]
栾立鹏,陈俊杰,顾闻,等.直肠肛管恶性黑色素瘤1例报告[J].中国血液流变学杂志, 2019, 29(3): 277-280, 302.
[16]
张森,高枫,陈利生,等.直肠肛管恶性黑色素瘤的临床特征分析[J].中华胃肠外科杂志, 2005, 8(4): 309-311.
[17]
Iddings DM, Fleisig AJ, Chen SL, et al. Practice patterns and outcomes for anorectal melanoma in the USA, reviewing three decades of treatment: is more extensive surgical resection beneficial in all patients? [J]. Ann Surg Oncol, 2010, 17(1): 40-44.
[18]
Jaiswal BS, Janakiraman V, Kljavin NM, et al. Combined targeting of BRAF and CRAF or BRAF and PI3K effector pathways is required for efficacy in NRAS mutant tumors[J]. PLoS One, 2009, 4(5): e5717.
[19]
Ascierto PA, Kirkwood JM, Grob JJ, et al. The role of BRAF V600 mutation in melanoma [J]. J Transl Med, 2012, 10: 85.
[20]
O'Donnell JS, Long GV, Scolyer RA, et al. Resistance to PD1/PDL1 checkpoint inhibition[J]. Cancer Treat Rev, 2017, 52: 71-81.
[1] 唐艳, 赵小虎, 栗玉姣, 顾向梅. 针刀治疗老年膝骨关节炎的肌骨超声特征与疗效相关性[J]. 中华关节外科杂志(电子版), 2024, 18(01): 48-53.
[2] 杨友涵, 文印宪, 陈廖斌. 噬菌体用于关节假体周围感染治疗的研究进展[J]. 中华关节外科杂志(电子版), 2024, 18(01): 125-130.
[3] 蒙礼娟, 麻艺群, 王璐, 张梦思, 范鑫, 许水淋, 杨丽红, 朱辉, 付晋凤. 采用SRT-100放射治疗儿童增生性瘢痕的临床疗效初探[J]. 中华损伤与修复杂志(电子版), 2024, 19(01): 16-23.
[4] 苏菲, 贾立群, 滕峰, 熊英, 高立伟, 张富强, 何凤娟, 夏莎莎, 刘春燕, 娄彦妮. 溃疡油联合复方维生素B12溶液外用防治放射性皮肤损伤的临床效果[J]. 中华损伤与修复杂志(电子版), 2024, 19(01): 51-56.
[5] 吴波, 郑永明, 杜世强. SPECT/CT及血清sTg水平预测甲状腺癌术后131I治疗患者淋巴结转移风险的价值分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(02): 212-216.
[6] 吴文娟, 王小莉, 刘娟. 乳腺结节微创手术治疗进展研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(02): 229-232.
[7] 沈海龙, 张建国, 邵一阳, 周晓超, 郭春来, 匡哲. 局部进展期低位直肠癌伴侧方淋巴短径<10 mm新辅助治疗后TME+LLND术的临床研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(02): 192-195.
[8] 程必盛, 黄海. 盆腔肿瘤手术后的"隐藏危机":泌尿功能障碍的防范与处理[J]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(01): 1-5.
[9] 任磊, 张瑞敏, 赵永祥. 隐睾患儿病因分析及临床诊疗进展[J]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(01): 100-104.
[10] 邓新军, 李正明, 李文彬. 广东省医学会泌尿外科疑难病例多学科会诊(第14期)——左肾原发恶性肿瘤并发于肺癌并脑转移[J]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(01): 114-117.
[11] 胡贤瑞, 伍振国, 何竟. 高压氧治疗创伤性脑损伤患者认知功能障碍疗效的Meta分析[J]. 中华脑科疾病与康复杂志(电子版), 2024, 14(01): 21-36.
[12] 潘晓帆, 徐勤义, 陆瑨, 王丹, 刘路路, 董万利. 颅内动脉瘤破裂介入术后并发脑疝的风险因素分析[J]. 中华脑科疾病与康复杂志(电子版), 2024, 14(01): 37-44.
[13] 陈涛, 石红建, 周良, 甘振. 介入治疗胃胆胰术后迟发性出血的临床疗效与安全性[J]. 中华介入放射学电子杂志, 2024, 12(01): 39-44.
[14] 崔皓然, 顾俊鹏, 任伟新. 基于经导管动脉化疗栓塞联合治疗肝癌伴门静脉癌栓的进展[J]. 中华介入放射学电子杂志, 2024, 12(01): 64-69.
[15] 胡浩, 曹葳, 何益兴, 安天志. 导管接触性溶栓治疗卵巢静脉血栓二例并文献复习[J]. 中华介入放射学电子杂志, 2024, 12(01): 90-92.
阅读次数
全文


摘要